Crovalimab (Anti-Complement C5)

Crovalimab (Anti-Complement C5) is a humanized recycling monoclonal antibody directed against the complement pathway protein C5, with potential complement pathway inhibitory and immunomodulating activities. MW : 145.28 KD.

• Supplier: Selleck Chemicals
• Product #: A2812
• Sku #: A2812-1mg